Most patients don’t get counselling about sex after heart attack
Most patients don’t receive counselling about resuming sexual activity after having a heart attack, according to new research.
Most patients don’t receive counselling about resuming sexual activity after having a heart attack, according to new research.
Most patients don’t receive counselling about resuming sexual activity after having a heart attack, according to new research.
by Gary Finnegan: The European Medicines Agency (EMA) has recommended 10 new medicines for approval, taking the total approvals for 2014 to 75 with one additional meeting still… read more.
by Bruce Sylvester: Estrogen blocking letrozole treatment results in higher birth rates in women with polycystic ovary syndrome (PCOS) than standard-therapy clomiphane, researchers reported on July 9, 2014… read more.
Controlling pain during childbirth and post delivery may reduce the risk of postpartum depression, writes Katherine Wisner, M.D., perinatal psychiatrist, in an editorial in Anesthesia & Analgesia.
Controlling childbirth pain appears to lower the risk of postpartum depression, researchers reported in a July 23 editorial in Anesthesia & Analgesia.
by Bruce Sylvester – taken from JAMA – Journal of the American Medical Association – A retrospective analysis of data on Danish women exposed to the nausea medication… read more.
FDA Highlights by Bruce Sylvester – Misoprostol vaginal insert used for labor induction has significantly reduced time to vaginal delivery compared with dinoprostone vaginal insert, researchers reported at… read more.
There is no high quality evidence that antioxidant supplements help to increase a woman’s chances of having a baby, according to the results of a new systematic review.
World Health Matters (INDIA) by Gary Finnegan – Women in India are more likely to avail of prenatal care when pregnant with boys, according to ground-breaking research that… read more.
When mothers in Norway ate probiotic-enhanced dairy products while pregnant, their children were less prone to eczema and nasal allergies during infancy and toddlerhood, a researcher said here.
The FDA has approved a selective estrogen receptor modulator (SERM) for treating pain associated with sexual intercourse in postmenopausal women.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.